YIBIN YANG
YIBIN YANG
Fox Chase Cancer Center
Verified email at fccc.edu
Title
Cited by
Cited by
Year
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma
Y Yang, AL Shaffer III, NCT Emre, M Ceribelli, M Zhang, G Wright, W Xiao, ...
Cancer cell 21 (6), 723-737, 2012
4312012
NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis
AK Pandey, Y Yang, Z Jiang, SM Fortune, F Coulombe, MA Behr, ...
PLoS Pathog 5 (7), e1000500, 2009
2662009
NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2
Y Yang, C Yin, A Pandey, D Abbott, C Sassetti, MA Kelliher
Journal of Biological Chemistry 282 (50), 36223-36229, 2007
2322007
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide
F Coulombe, M Divangahi, F Veyrier, L de LÚsÚleuc, JL Gleason, Y Yang, ...
Journal of Experimental Medicine 206 (8), 1709-1716, 2009
2172009
Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains
DW Abbott, Y Yang, JE Hutti, S Madhavarapu, MA Kelliher, LC Cantley
Molecular and cellular biology 27 (17), 6012-6025, 2007
1952007
Pathogenetic importance and therapeutic implications of NF‐κB in lymphoid malignancies
KH Lim, Y Yang, LM Staudt
Immunological reviews 246 (1), 359-378, 2012
1482012
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors
M Ceribelli, PN Kelly, AL Shaffer, GW Wright, W Xiao, Y Yang, LAM Griner, ...
Proceedings of the National Academy of Sciences 111 (31), 11365-11370, 2014
1432014
A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-κB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage
Y Yang, F Xia, N Hermance, A Mabb, S Simonson, S Morrissey, P Gandhi, ...
Molecular and cellular biology 31 (14), 2774-2786, 2011
1202011
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms
Y Yang, R Schmitz, J Mitala, A Whiting, W Xiao, M Ceribelli, GW Wright, ...
Cancer discovery 4 (4), 480-493, 2014
1182014
Selective interleukin-1 receptor–associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
PN Kelly, DL Romero, Y Yang, AL Shaffer III, D Chaudhary, S Robinson, ...
Journal of Experimental Medicine 212 (13), 2189-2201, 2015
1022015
Targeting non-proteolytic protein ubiquitination for the treatment of diffuse large B cell lymphoma
Y Yang, P Kelly, AL Shaffer III, R Schmitz, HM Yoo, X Liu, D Webster, ...
Cancer cell 29 (4), 494-507, 2016
702016
Targeting the HTLV-I-regulated BATF3/IRF4 transcriptional network in adult T cell leukemia/lymphoma
M Nakagawa, AL Shaffer III, M Ceribelli, M Zhang, G Wright, W Xiao, ...
Cancer Cell 34 (2), 286-297. e10, 2018
352018
Activation of NOD receptors by Neisseria gonorrhoeae modulates the innate immune response
N Mavrogiorgos, S Mekasha, Y Yang, MA Kelliher, RR Ingalls
Innate immunity 20 (4), 377-389, 2014
332014
Disruption of thrombocyte and T lymphocyte development by a mutation in ARPC1B
R Somech, A Lev, YN Lee, AJ Simon, O Barel, G Schiby, C Avivi, ...
The Journal of Immunology 199 (12), 4036-4045, 2017
322017
A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice
KM Draheim, N Hermance, Y Yang, E Arous, J Calvo, MA Kelliher
Oncogene 30 (10), 1252-1260, 2011
282011
Phase II study of the PD-1 inhibitor pembrolizumab for the treatment of relapsed or refractory mature T-cell lymphoma
SK Barta, J Zain, AW MacFarlane IV, SM Smith, J Ruan, HC Fung, CR Tan, ...
Clinical Lymphoma Myeloma and Leukemia 19 (6), 356-364. e3, 2019
222019
A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening
JP Zhang, Z Song, HB Wang, L Lang, YZ Yang, W Xiao, DE Webster, ...
blood 134 (2), 171-185, 2019
122019
Enhanced SLAMF7 homotypic interactions by elotuzumab improves NK cell killing of multiple myeloma
T Pazina, AM James, KB Colby, Y Yang, A Gale, A Jhatakia, AY Kearney, ...
Cancer immunology research 7 (10), 1633, 2019
62019
A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-κB and p38 MAP kinase/MAPKAP-2 responses to DNA damage
Y Yang, F Xia, N Hermance, A Mabb, S Simonson, S Morrissey, P Gandhi, ...
Molecular and Cellular Biology, 2011
52011
A20 and RBX1 regulate brentuximab vedotin sensitivity in Hodgkin Lymphoma models
W Wei, Y Lin, Z Song, W Xiao, L Chen, J Yin, Y Zhou, SK Barta, M Petrus, ...
Clinical Cancer Research, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20